163 related articles for article (PubMed ID: 34408997)
21. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
Lancman G; Mascarenhas J; Bar-Natan M
J Hematol Oncol; 2020 Oct; 13(1):131. PubMed ID: 33008453
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
23. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.
Anderson J; Schauer J; Bryant S; Graves CR
Case Rep Womens Health; 2020 Jul; 27():e00221. PubMed ID: 32426243
[TBL] [Abstract][Full Text] [Related]
24. Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Sturek JM; Thomas TA; Gorham JD; Sheppard CA; Raymond AH; Petros De Guex K; Harrington WB; Barros AJ; Madden GR; Alkabab YM; Lu DY; Liu Q; Poulter MD; Mathers AJ; Thakur A; Schalk DL; Kubicka EM; Lum LG; Heysell SK
Microbiol Spectr; 2022 Feb; 10(1):e0256021. PubMed ID: 35196802
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or Lymphoma.
Hashmi SK; Bodea J; Patni T; Angel S; Bhakta NH; Jeha S; Karol SE; Ribeiro RC; Rubnitz JE; Wolf J; Li Y; Pui CH; Hijano DR; Inaba H
JAMA Netw Open; 2024 Feb; 7(2):e2355727. PubMed ID: 38363571
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity.
Kremer AE; Kremer AN; Willam C; Völkl S; Verhagen J; Achenbach S; van der Meijden ED; Lang V; Aigner M; Maier C; Tenbusch M; Korn K; Lutzny-Geier G; Spoerl S; Strauß R; Vetter M; Überla K; Neurath MF; Mackensen A; Schiffer M; Hackstein H
Eur J Immunol; 2021 Oct; 51(10):2478-2484. PubMed ID: 34350584
[TBL] [Abstract][Full Text] [Related]
27. Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
Tremblay D; Seah C; Schneider T; Bhalla S; Feld J; Naymagon L; Wang B; Patel V; Jun T; Jandl T; Rahman F; Liu STH; Aberg JA; Bouvier N;
Cancer Med; 2020 Nov; 9(22):8571-8578. PubMed ID: 32945149
[TBL] [Abstract][Full Text] [Related]
28. Remdesivir for the treatment of COVID-19.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
[TBL] [Abstract][Full Text] [Related]
29. Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509
[TBL] [Abstract][Full Text] [Related]
30. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
[TBL] [Abstract][Full Text] [Related]
31. Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.
D'Abramo A; Vita S; Maffongelli G; Beccacece A; Agrati C; Cimini E; Colavita F; Giancola ML; Cavasio A; Nicastri E;
Front Immunol; 2022; 13():911339. PubMed ID: 35711444
[TBL] [Abstract][Full Text] [Related]
32. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
33. Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia.
Cacho J; Burgos E; Molina M; Villegas A; Pérez M; Cañas L; Taco O; Juega J; Lauzurica R
Nefrologia (Engl Ed); 2022; 42(3):311-317. PubMed ID: 36210620
[TBL] [Abstract][Full Text] [Related]
34. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
35. Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients.
Thümmler L; Lindemann M; Horn PA; Lenz V; Konik M; Gäckler A; Boss K; Theodoropoulos F; Besa V; Taube C; Brenner T; Witzke O; Krawczyk A; Rohn H
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680159
[TBL] [Abstract][Full Text] [Related]
36. The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study.
Pan C; Chen H; Xie J; Huang Y; Yang Y; Du B; Qiu H
Front Med (Lausanne); 2022; 9():822821. PubMed ID: 35783610
[TBL] [Abstract][Full Text] [Related]
37. Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge.
Khan AM; Ajmal Z; Raval M; Tobin E
Cureus; 2020 Aug; 12(8):e9629. PubMed ID: 32923230
[TBL] [Abstract][Full Text] [Related]
38. Migratory Pulmonary Infiltrates in a B-Cell-Depleted COVID-19 Patient.
Zhu W; Xie T; Xu M; Chen R; Zhang T
Infect Drug Resist; 2023; 16():7205-7208. PubMed ID: 38023406
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
40. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
Contini C; Enrica Gallenga C; Neri G; Maritati M; Conti P
Med Hypotheses; 2020 Nov; 144():109876. PubMed ID: 32562915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
